Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Adults with a BMI of 27 or above who also have at least one weight-related health condition, such as type 2 diabetes, high blood pressure, or high cholesterol
Source:Eli Lilly and Company First Phase 3 retatrutide trial appears in a peer-reviewed journal TRANSCEND-T2D-1 was published in The Lancet the first and, so far, only Phase 3 retatrutide trial to be externally peer reviewed rather than reported only by the sponsor
The exact dosage is dependent on medical condition, response to the treatment, age, and weight
[3] This glutathione conjugation system is essential for processing environmental toxins, alcohol metabolites, and pharmaceutical compounds
The protein content typically ranges from 85% to 92% by weight, with the rest being moisture and trace minerals
